Fremont, Calif.-based Visunex Medical Systems has won FDA clearance for its PanoCam LT wide-field imaging system for newborn infants.

A wireless imaging system, PanoCam LT is designed to detect external, anterior and posterior segment vision disorders that may result in negative long-term effects on the vision.

Vision disorders may affect between 10 and 20 percent of newborns worldwide, according to the company.

Visunex adds that early detection of retinal hemorrhages and other disorders can lead to prompt intervention and potentially prevent vision loss. — Michael Cipriano